Today, U.S. Congressman Bob Latta (R-OH05) and U.S. Senator Hyde-Smith (R-Miss.) led 75 of their colleagues from the U.S. House of Representatives and Senate in calling for the U.S. Food and Drug Administration (FDA) to reverse its illegal actions in promoting mail-order chemical abortion drugs.
In the letter to FDA Commissioner Robert Califf, M.D., the lawmakers explain the policy and… Read more »
Today, Congressman Bob Latta (R-OH5) joined Ohioans and Americans from across the country at the 2023 March for Life held on the National Mall in Washington, D.C. and hosted a pro-life reception providing a legislative update for over 100 individuals from Ohio in the Rayburn House Office Building.
“I believe every single life is precious, and that it is our duty to… Read more »
Today, Congressman Bob Latta (R-OH5) voted against the radical “Abortion on Demand Up Until Birth Act” that would codify and expand the Roe v. Wade framework to allow abortions up to birth, allow for discriminatory abortions on the basis of a baby’s sex, race, and disability, gut commonsense state restrictions on abortion, and ban state parental notification laws. The abortion… Read more »
Today, Congressman Bob Latta (R-OH5) provided the following statement regarding the U.S. Supreme Court’s opinion in the Dobbs v. Jackson Women’s Health Organization case.
“Today, we celebrate life and all of those who are committed to protecting and defending the most innocent among us – the unborn,” said Latta. “The Supreme Court’s decision overturns the wrongly-decided Roe v. Wade… Read more »
Congressman Bob Latta (R-OH) addressed the ongoing baby formula crisis in an op-ed that appeared in today’s Findlay Courier. Latta laid out how the situation got to this point and the efforts he’s supporting to fix the problem. Latta is a senior member of the House Energy and Commerce Committee, which has oversight over the U.S. Food and Drug Administration. Click here to read the piece… Read more »
Congressman Bob Latta (R-Ohio) and U.S. Senator Cindy Hyde-Smith (R-Miss.), with 124 colleagues from the Senate and House of Representatives, this month demanded the U.S. Food and Drug Administration (FDA) immediately restore more stringent oversight of chemical abortion bills, including the in-person dispensing requirement the FDA suspended in December.
The lawmakers issued a letter… Read more »
Yesterday, Congressman Bob Latta (R-OH5) received notice that he earned an A+ rating on the Susan B. Anthony List’s National Pro-Life Scorecard. This new score takes into account votes and actions for every member of Congress for the first session of the 117th Congress. Included in this year’s score card is co-sponsorship of Latta’s legislation, the Support and Value Expectant (SAVE) Moms… Read more »
Today, Congressman Bob Latta (R-OH5) asked for Unanimous Consent on the House floor to force a vote on H.R. 18, the No Taxpayer Funding for Abortion Act, which would prohibit taxpayer dollars from being used to support and enable the abortion industry. Latta is a cosponsor of H.R.18.
… Read more »
Today, Congressman Bob Latta (R-OH5) and Senator Cindy Hyde-Smith (R-MS), with 114 colleagues from the U.S. House of Representatives and the U.S. Senate, today sent the U.S. Food and Drug Administration (FDA) a letter recommending against further weakening of the Risk Evaluation and Mitigation Strategy (REMS) for mifepristone, a chemical abortion drug.
The signed bicameral letter… Read more »
Today, Congressman Bob Latta (R-OH5) signed onto a discharge petition that would force a vote on the Born-Alive Abortion Survivors Protection Act, H.R. 619, if it reaches the required 218 signatures. House Republicans have attempted to bring the legislation to the House floor for a vote over seventy-five times, but the bill has been blocked by Democratic leadership each time. In both the… Read more »
